Skip to content

Vasilios Papademetriou, MD

NPI 1003906207ActiveIndividual· Internal Medicine, Cardiovascular Disease· Washington, DC

Internal Medicine, Cardiovascular Disease (MD) in Washington, District of Columbia, licensed in DC, with an NPI issued in October 2006. Part D covered 22 prescriptions written in 2024, 91% of them generic. Novartis Pharmaceuticals Corporation reported $11,213 in payments in 2024, mostly consulting fees.

Overview

NPI1003906207
StatusActive
Entity typeIndividual
CredentialMD
Sole proprietorNo
NPI issuedOct 16, 2006
Last updated in NPPESJul 8, 2007

Specialties and licenses

TaxonomyCodeLicenseState
Internal Medicine, Cardiovascular Disease Primary207RC0000XMD20084DC

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Not in the public enrollment file of Oct 1, 2026

Part D prescriptions in 2024

Prescriptions (claims)22 · 62 30-day fills
Total drug cost$1,608
Generic share91% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2024$11,213 · 5 payments from 1 company

Top paying companies in 2024

CompanyAmountPayments
Novartis Pharmaceuticals Corporation$11,2135

What the 2024 payments were for

  • Consulting Fee$10,000 · 1 payment
  • Travel and Lodging$1,105 · 3 payments
  • Food and Beverage$107.93 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other cardiologists in Washington

All 156 cardiologists in Washington · All cardiologists in District of Columbia